FDA — authorised 4 April 2003
- Marketing authorisation holder: MARATHON PHARMS LLC
- Status: approved
🇺🇸 Revasc in United States
FDA authorised Revasc on 4 April 2003
Marketing authorisation
Revasc in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Revasc approved in United States?
Yes. FDA authorised it on 4 April 2003.
Who is the marketing authorisation holder for Revasc in United States?
MARATHON PHARMS LLC holds the US marketing authorisation.